The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Chronic Nitric Oxide Inhibition Model Six Years On
Open accessAbstract
T he discovery in 1987 that endothelium-derived nitric oxide (NO) mediates the vasodilatory effect of certain endothelium-dependent agonists 1,2 inaugurated the current huge field of NO biology.It is now recognized that NO plays essential roles in many diverse physiological processes and in some pathophysiologic events.Development of these concepts has been based largely on evidence obtained by limiting NO biosynthesis.This review is centered on the cardiovascular and particularly the renal functional and structural consequences of chronic pharmacologic NO inhibition by L-arginine analogues.We devoted special attention to the mechanisms of hypertension and organ injury that occur under these circumstances, while appreciating the inherent limitations surrounding interpretation of this data. Ubiquity and Heterogeneity of NO BiosynthesisNO is made by the enzymatic action of several widely distributed NO synthases (NOS).In the presence of the substrates L-arginine and oxygen, as well as a number of essential cofactors, NO is produced in response to appropriate stimuli.The constitutively expressed NOS play a major role in the physiological control of vascular tone and kidney function.3,4 Vascular endothelial NOS (eNOS) and brain-type NOS (bNOS) are widely distributed throughout the kidney 5 as well as the cardiovascular system and in strategic locations in the peripheral and central nervous system (CNS).6,7 Both eNOS and particularly bNOS are abundant in the kidney, glomeruli, and vasculature as well as in most segments of the tubule, 3,5 and NOS activity in medulla is considerably greater than in cortex.8 NO generated within the kidney controls the glomerular filtration rate (GFR), total renal and medullary blood flow, pressure natriuresis, epithelial sodium transport, and production of various vasoactive factors including renin.[3][4][5] eNOS is distributed throughout most parts of the arterial and venous circulation, although there is considerable heterogeneity in the extent to which NO controls tone in regional circulations.9 Although there is some basal NO release from eNOS, shear stress is the physiologically important regulator of vascular NO production.3 In the CNS, NO is made in the nucleus tractus solitarius, the paraventricular nucleus, and the ventral medulla and can control sympathetic outflow.6,10 In addition to central regulation of efferent renal sympathetic nerve activity, there is direct nitrergic innervation to several locations including the renal vasculature.7
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Role of endothelium-derived nitric oxide in the regulation of blood pressure.
Rees, D. D., Palmer, R. M., & Moncada, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3375 · Cited by 1,826
Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro, M. O., Antunes, E., de Nucci, G., Lovisolo, S. M., & Zatz, R. (1992) · Hypertension · doi:10.1161/01.hyp.20.3.298 · Cited by 786
Self-citationBaylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729
Self-citationBehavioural abnormalities in male mice lacking neuronal nitric oxide synthase
Nelson, R. J., Demas, G. E., Huang, P. L., Fishman, M. C., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1995) · Nature · doi:10.1038/378383a0 · Cited by 595
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
Laubach, V. E., Shesely, E. G., Smithies, O., & Sherman, P. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10688 · Cited by 580
Nitric oxide synthase in macula densa regulates glomerular capillary pressure.
Wilcox, C. S., Welch, W. J., Murad, F., Gross, S. S., Taylor, G., Levi, R., & Schmidt, H. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11993 · Cited by 523
L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.
Chen, P. Y., & Sanders, P. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115467 · Cited by 450
Cited by
Sex differences in primary hypertension
Sandberg, K., & Ji, H. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-7 · Cited by 442
Nitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
Self-citationQuercetin and metabolic syndrome: A review
Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 386
Animal Models of Hypertension: A Scientific Statement From the American Heart Association
Lerman, L. O., Kurtz, T. W., Touyz, R. M., Ellison, D. H., Chade, A. R., Crowley, S. D., Mattson, D. L., Mullins, J. J., Osborn, J., Eirin, A., et al. (2019) · Hypertension · doi:10.1161/hyp.0000000000000090 · Cited by 329
Antihypertensive effects of the flavonoid quercetin
Perez-Vizcaino, F., Duarte, J., Jimenez, R., Santos-Buelga, C., & Osuna, A. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70008-8 · Cited by 316
Vascular and renal function in experimental thyroid disorders
Vargas, F., Moreno, J. M., Rodríguez-Gómez, I., Wangensteen, R., Osuna, A., Álvarez-Guerra, M., & García-Estañ, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02093 · Cited by 285
Hansell, P., Welch, W. J., Blantz, R. C., & Palm, F. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12034 · Cited by 269
Total nitric oxide production is low in patients with chronic renal disease
Schmidt, R. J., & Baylis, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00281.x · Cited by 252
Self-citationStasch, J., Dembowsky, K., Perzborn, E., Stahl, E., & Schramm, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704483 · Cited by 120
Metadata
- Authors
- Zatz, R., & Baylis, C.
- Venue
- Hypertension
- Published
- 1998-12
- Volume
- 32
- Issue
- 6
- Pages
- 958-964
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1995116171
- Cited by
- 255
- References
- 71
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.